We a good story
Quick delivery in the UK

New Targets for the Treatment of Hypertension and Associated Diseases

About New Targets for the Treatment of Hypertension and Associated Diseases

New Targets for the Treatment of Hypertension and Associated Diseases, Volume 94 in the Advances in Pharmacology serial, highlights new advances in the field, with this new volume presenting interesting chapters on Cytochrome P450, 20-hydroxyeicosatetraenoic acid and GPR75 pathway in hypertension, Treatment of hypertension with soluble epoxide hydrolase inhibitors, Effects of allosteric modifiers of adenosine receptors in the heart, Orally active epoxyeicosatrienoic acid analogs in hypertension and renal injury, Drugs affecting the nitric oxide- cyclic GMP pathway in hypertension, Relaxin-2 and Serelaxin in renal and cardiac dysfunction in hypertension, and more. Provides the authority and expertise of leading contributors from an international board of authors Presents the latest release in Advances in Pharmacology series Updated release includes the latest information on New Targets for the Treatment of Hypertension and Associated Diseases

Show more
  • Language:
  • English
  • ISBN:
  • 9780323910873
  • Binding:
  • Hardback
  • Pages:
  • 420
  • Published:
  • June 6, 2022
  • Dimensions:
  • 152x229x0 mm.
  • Weight:
  • 450 g.
Delivery: 2-3 weeks
Expected delivery: June 6, 2025

Description of New Targets for the Treatment of Hypertension and Associated Diseases

New Targets for the Treatment of Hypertension and Associated Diseases, Volume 94 in the Advances in Pharmacology serial, highlights new advances in the field, with this new volume presenting interesting chapters on Cytochrome P450, 20-hydroxyeicosatetraenoic acid and GPR75 pathway in hypertension, Treatment of hypertension with soluble epoxide hydrolase inhibitors, Effects of allosteric modifiers of adenosine receptors in the heart, Orally active epoxyeicosatrienoic acid analogs in hypertension and renal injury, Drugs affecting the nitric oxide- cyclic GMP pathway in hypertension, Relaxin-2 and Serelaxin in renal and cardiac dysfunction in hypertension, and more. Provides the authority and expertise of leading contributors from an international board of authors Presents the latest release in Advances in Pharmacology series Updated release includes the latest information on New Targets for the Treatment of Hypertension and Associated Diseases

User ratings of New Targets for the Treatment of Hypertension and Associated Diseases



Find similar books
The book New Targets for the Treatment of Hypertension and Associated Diseases can be found in the following categories:

Join thousands of book lovers

Sign up to our newsletter and receive discounts and inspiration for your next reading experience.